Athira Pharma, Inc. (ATHA)

Athira Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	97	92	120	487	1,113	-
Market Cap Growth	10.70%	-22.89%	-75.36%	-56.26%	-	-
Enterprise Value	-25	-54	-79	235	929	-1
PE Ratio	-	-0.79	-1.25	-8.87	-55.76	-
PB Ratio	0.90	0.71	0.51	1.52	4.06	-
P/FCF Ratio	-1.05	-0.92	-1.63	-10.89	-42.09	-
P/OCF Ratio	-1.05	-0.92	-1.65	-11.29	-46.14	-
EV/EBITDA Ratio	0.14	0.46	0.83	-4.33	-46.56	0.10
EV/EBIT Ratio	0.14	0.46	0.83	-4.28	-46.55	0.10
EV/FCF Ratio	0.16	0.53	1.07	-5.26	-35.14	0.14
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.00	-0.08
Debt / EBITDA Ratio	-0.01	-0.01	-0.02	-0.04	-0.05	-0.30
Debt / FCF Ratio	-0.01	-0.02	-0.03	-0.04	-0.04	-0.42
Quick Ratio	4.79	5.13	9.43	27.56	42.22	1.62
Current Ratio	5.03	5.37	9.68	28.07	43.66	1.70
Return on Equity (ROE)	-80.60%	-69.10%	-35.40%	-16.00%	-15.70%	29.80%
Return on Assets (ROA)	-67.70%	-59.90%	-33.60%	-15.60%	-14.20%	-144.90%
Return on Capital (ROIC)	-113.99%	-95.21%	-43.88%	-19.82%	-7.26%	29.99%
Earnings Yield	-120.29%	-127.25%	-79.75%	-11.27%	-1.79%	-
FCF Yield	-103.98%	-109.28%	-61.38%	-9.18%	-2.38%	-
Buyback Yield / Dilution	-1.05%	-0.76%	-2.20%	-208.53%	-235.50%	-2.82%
Total Shareholder Return	-1.05%	-0.76%	-2.20%	-208.53%	-235.50%	-2.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).